BlackRock Inc. - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 17 filers reported holding VIRPAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$371
-25.9%
4640.0%0.00%
Q2 2023$501
+37.6%
4640.0%0.00%
Q1 2023$364
+26.0%
4640.0%0.00%
Q4 2022$289
-71.1%
4640.0%0.00%
Q3 2022$1,0000.0%4640.0%0.00%
Q2 2022$1,0000.0%4640.0%0.00%
Q1 2022$1,000
-50.0%
4640.0%0.00%
Q4 2021$2,0004640.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 988,165$614,9350.54%
Quantum Private Wealth, LLC 10,000$6,2230.00%
Warberg Asset Management LLC 17,012$10,5610.00%
Belpointe Asset Management LLC 19,045$11,8520.00%
OSAIC HOLDINGS, INC. 600$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$62,7440.00%
WELLS FARGO & COMPANY/MN 59$370.00%
NORTHERN TRUST CORP 15,221$9,4720.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,038$410.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders